Storage-stable ready-to-use formulations of tigecycline
Liquid parenteral formulations are provided that include tigecycline and at least one or more pharmaceutically acceptable excipient or adjuvant, where the formulation is ready to use without additional steps for reconstitution at the time of administration.
1. A liquid ready to use parenteral formulation, comprising tigecycline, calcium chloride, sodium chloride, sodium bisulfite, and optionally an amino acid selected from L-Histidine, L-Cysteine HCl or L-arginine; wherein concentration of tigecycline in the ready to use parenteral formulation is from 1 mg/ml to about 5 mg/ml and pH of the ready to use parenteral formulation is from 5.5 to 6.5.
2. The formulation of claim 1 , provided as a 100 ml, nitrogen flushed solution.
3. The formulation of claim 1 , provided as a 5 ml, nitrogen flushed solution.